[
    [
        {
            "time": "2023-02-01",
            "original_text": "Pacific Biosciences (PACB) Q4 Earnings and Revenues Miss Estimates",
            "features": {
                "keywords": [
                    "PACB",
                    "Q4",
                    "Earnings",
                    "Revenues",
                    "Miss",
                    "Estimates"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Pacific Biosciences (PACB) Q4 Earnings and Revenues Miss Estimates",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-02-01",
            "original_text": "Why You Should Retain Abiomed (ABMD) Stock in Your Portfolio",
            "features": {
                "keywords": [
                    "Abiomed",
                    "ABMD",
                    "Stock",
                    "Portfolio",
                    "Retain"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Why You Should Retain Abiomed (ABMD) Stock in Your Portfolio",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-02-01",
            "original_text": "LabCorp (LH) Q4 Earnings Beat Estimates, Margins Expand",
            "features": {
                "keywords": [
                    "LabCorp",
                    "LH",
                    "Q4",
                    "Earnings",
                    "Beat",
                    "Estimates",
                    "Margins",
                    "Expand"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "LabCorp (LH) Q4 Earnings Beat Estimates, Margins Expand",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-02-01",
            "original_text": "Cerner (CERN) Q4 Earnings Match Estimates, Revenues Beat",
            "features": {
                "keywords": [
                    "Cerner",
                    "CERN",
                    "Q4",
                    "Earnings",
                    "Match",
                    "Estimates",
                    "Revenues",
                    "Beat"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare IT"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Cerner (CERN) Q4 Earnings Match Estimates, Revenues Beat",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-02-01",
            "original_text": "HEXO Soars: Stock Adds 7.9% in Session",
            "features": {
                "keywords": [
                    "HEXO",
                    "Soars",
                    "Stock",
                    "Adds",
                    "7.9%",
                    "Session"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "cannabis"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "HEXO Soars: Stock Adds 7.9% in Session",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-02-01",
            "original_text": "Forget Moderna! This Is a More Lucrative Coronavirus Stock",
            "features": {
                "keywords": [
                    "Moderna",
                    "Coronavirus",
                    "Stock",
                    "Lucrative"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Forget Moderna! This Is a More Lucrative Coronavirus Stock",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 10,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-02-01",
            "original_text": "4 Top COVID Stocks to Buy in February",
            "features": {
                "keywords": [
                    "COVID",
                    "Stocks",
                    "Buy",
                    "February"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "4 Top COVID Stocks to Buy in February",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]